Waste to energy Linhai

The emerging waste to energy company in China with the latest leading Biotech raising 30m with total equity valuation of USD200m as round B, the corporate accept both project developer investor (project base with consession agreement of 35 year PPP format) or permanant equity investor. after 20 years of R&D, the chief scientist and founder Mr Zhu established the company in 2020 with the cracking and patented technologies in biotech which transforms biowaste to biogas, green hydrogen and green electricity, with by-product of new material and fertiliser with zero waste generated. With strong support from the government and consession agreement, the project resolve the total biowaste of the city and turn profitable in 2021 with annual growth rate more than 50%. The project has been selected to be the top 3 ESG project by program President Xi's timezone by CCTV. Fund raised is to replicate the success model to other cities in China with estimated financials as below: Net Profit 2023 onwards by estimations USDm (growth rate) 2020: -1.5 2021: 0.7m 2022: 5m (615%) 2023: 7m (40%) 2024: 15m (114%) 2025: 24m (60%) 2026: 44m (83%)